Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ADMA Biologics, Inc.
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 19, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 03, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Amendment to Credit Agreement
May 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
February 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
January 17, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
December 13, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 09, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 07, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Proposed Public Offering of Common Stock
December 06, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
December 06, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
November 02, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
October 31, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.